SEC Form 4 · accession 0001288123-18-000014
AGENUS INC · AGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shalini Sharp
Director
Period of report
Mar 2, 2018
Accepted (ET)
Jun 22, 2018 · 12:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001098972
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option, right to buy | $5.65 | Mar 2, 2018 | A | 18,533 | A | Mar 2, 2019 | Mar 2, 2028 | Common Stock | 18,533 | 18,533 | D |
| Stock Option, right to buyF1 | $5.65 | Jun 20, 2018 | A | 37,500 | A | Mar 2, 2019 | Mar 2, 2028 | Common Sotck | 37,500 | 37,500 | D |
| Stock Option, right to buy | $2.50 | Jun 21, 2018 | A | 10,000 | A | Jun 21, 2019 | Jun 21, 2028 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1Option was granted on March 2, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan, vesting on March 2, 2019